The Discounted Cash Flow (DCF) valuation of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505.SS) is 10.18 CNY. With the latest stock price at 7.96 CNY, the upside of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd based on DCF is 27.8%.
Based on the latest price of 7.96 CNY and our DCF valuation, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505.SS) is a buy. buying 688505.SS stocks now will result in a potential gain of 27.8%.
| Range | Selected | |
| WACC / Discount Rate | 8.8% - 11.5% | 10.2% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 10.00 - 10.27 | 10.18 |
| Upside | 25.6% - 29.1% | 27.8% |